Genesis Healthcare, Inc. (GENN)
Total Valuation
GENN has a market cap or net worth of $602,462. The enterprise value is $3.46 billion.
Market Cap | 602,462 |
Enterprise Value | 3.46B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
GENN has 167.35 million shares outstanding. The number of shares has decreased by -32.37% in one year.
Shares Outstanding | 167.35M |
Shares Change (YoY) | -32.37% |
Shares Change (QoQ) | +0.13% |
Owned by Insiders (%) | 33.68% |
Owned by Institutions (%) | n/a |
Float | 74.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 0.01 |
PS Ratio | n/a |
Forward PS | 0.00 |
PB Ratio | n/a |
P/FCF Ratio | 0.01 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.76, with a EV/FCF ratio of 65.49.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | 11.76 |
EV / EBIT | 47.46 |
EV / FCF | 65.49 |
Financial Position
Current Ratio | 0.23 |
Quick Ratio | 0.20 |
Debt / Equity | n/a |
Debt / EBITDA | 12.96 |
Debt / FCF | 72.16 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -1.40% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 44,000 |
Asset Turnover | 0.91 |
Inventory Turnover | n/a |
Taxes
Income Tax | -3.61M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.50% in the last 52 weeks. The beta is 0.12, so GENN's price volatility has been lower than the market average.
Beta (1Y) | 0.12 |
52-Week Price Change | -98.50% |
50-Day Moving Average | 0.07 |
200-Day Moving Average | 0.13 |
Average Volume (30 Days) | 35,655 |
Short Selling Information
The latest short interest is 2.30 million, so 1.38% of the outstanding shares have been sold short.
Short Interest | 2.30M |
Short % of Shares Out | 1.38% |
Short % of Float | 3.08% |
Short Ratio (days to cover) | 0.21 |
Income Statement
Revenue | n/a |
Gross Profit | 2.27B |
Operating Income | -483.06M |
Pretax Income | -62.57M |
Net Income | -58.96M |
Net Income Common | n/a |
EBITDA | 294.02M |
EBIT | 72.87M |
Earnings Per Share (EPS) | -$0.53 |
Balance Sheet
The company has $352.75 million in cash and $3.81 billion in debt, giving a net cash position of -$3.46 billion or -$20.66 per share.
Cash & Cash Equivalents | 352.75M |
Total Debt | 3.81B |
Net Cash | -3.46B |
Net Cash Per Share | -$20.66 |
Book Value | -820.22M |
Book Value Per Share | -4.90 |
Working Capital | -2.98B |
Cash Flow
In the last 12 months, operating cash flow was $315.73 million and capital expenditures -$262.93 million, giving a free cash flow of $52.80 million.
Operating Cash Flow | 315.73M |
Capital Expenditures | -262.93M |
Free Cash Flow | 52.80M |
FCF Per Share | $0.32 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GENN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | n/a |
FCF Yield | 8,764.37% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | 32.34% |
Shareholder Yield | 32.34% |
Analyst Forecast
The average price target for GENN is $0.44, which is 12,122.22% higher than the current price. The consensus rating is "Sell".
Price Target | $0.44 |
Price Target Difference | 12,122.22% |
Analyst Consensus | Sell |
Analyst Count | 6 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |